Medicare Enrolled

Dr. Zachary Klaassen, M.D.

Urology Physician · Augusta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1120 15TH ST, Augusta, GA 30912
7067212519
In practice since 2011 (15 years)
NPI: 1891082772 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Klaassen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Klaassen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Klaassen

Dr. Zachary Klaassen is an urology physician in Augusta, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Klaassen performed 482 Medicare services across 357 unique beneficiaries.

Between the years covered by Open Payments, Dr. Klaassen received a total of $471,639 from 45 pharmaceutical and/or device companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Klaassen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 482 Medicare services $471,639 industry payments

Medicare Practice Summary

Medicare Utilization ↗
482
Medicare services
Bottom 18% in GA for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
357
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
196 $47 $111
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
82 $58 $492
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
66 $49 $127
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $74 $172
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
24 $102 $1,089
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
24 $104 $283
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
16 $58 $165
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
12 $107 $774
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
12 $65 $218
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
0.0% medium
92.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$471,639
Total received (2018-2024)
Avg $67,377/year across 7 years
Top 1% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
434
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$363,843 (77.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$102,334 (21.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,463 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$258,921
2023
$167,730
2022
$39,386
2021
$3,446
2020
$294
2019
$1,562
2018
$301

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$112,855
Bayer Healthcare Pharmaceuticals Inc.
$71,561
PROGENICS PHARMACEUTICALS, INC.
$36,984
UROGEN PHARMA, INC.
$23,432
Astellas Pharma US Inc
$7,027
Novartis Pharmaceuticals Corporation
$2,345
Telix Pharmaceuticals
$1,420
Astellas Pharma Global Development
$938
Janssen Global Services, LLC
$880
Axonics, Inc.
$372
PROCEPT BioRobotics Corporation
$229
Blue Earth Diagnostics Limited
$159
BIOTISSUE HOLDINGS INC.
$118
Ferring Pharmaceuticals Inc.
$113
Medtronic, Inc.
$105
AngioDynamics, Inc.
$91
Janssen Scientific Affairs, LLC
$76
COLOPLAST CORP
$54
Boston Scientific Corporation
$54
Merck Sharp & Dohme LLC
$51
Innovation Technologies Inc
$36
Ambu Inc.
$20
Top 3 companies account for 85.5% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer Healthcare Pharmaceuticals Inc.
$118,219
Teleflex LLC
$113,036
PALETTE LIFE SCIENCES, INC.
$82,954
Progenics Pharmaceuticals, Inc.
$70,499
PROGENICS PHARMACEUTICALS, INC.
$36,984
UROGEN PHARMA, INC.
$23,453
Astellas Pharma US Inc
$7,126
PFIZER INC.
$3,942
Janssen Global Services, LLC
$2,740
Astellas Pharma Global Development
$2,692
Novartis Pharmaceuticals Corporation
$2,427
Telix Pharmaceuticals
$1,420
Blue Earth Diagnostics Limited
$1,263
Cook Medical LLC
$881
Axonics, Inc.
$561
Boston Scientific Corporation
$367
NeoTract Inc.
$268
Coloplast Corp
$255
PROCEPT BioRobotics Corporation
$229
BOSTON SCIENTIFIC CORPORATION
$223
Palette Life Sciences, Inc.
$213
COLOPLAST CORP
$184
Merck Sharp & Dohme LLC
$177
UroGen Pharma, Inc.
$167
Janssen Biotech, Inc.
$156
ACELL, INC.
$125
Aroa Biosurgery Incorporated
$119
BIOTISSUE HOLDINGS INC.
$118
Ferring Pharmaceuticals Inc.
$113
Janssen Scientific Affairs, LLC
$109
Medtronic, Inc.
$105
Myovant Sciences Inc.
$94
AngioDynamics, Inc.
$91
Ambu Inc.
$50
Richard Wolf Medical Instruments Corp.
$45
Baxter Healthcare
$40
Innovation Technologies Inc
$36
Becton, Dickinson and Company
$31
Olympus America Inc.
$30
Merck Sharp & Dohme Corporation
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
Dornier MedTech America, Inc
$20
Covidien LP
$18
AstraZeneca Pharmaceuticals LP
$14
Travere Therapeutics, Inc.
$4
Top 3 companies account for 66.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · AMS · AQUABEAM SYSTEM · Axonics · Axumin · Bard Urinary Drainage Bag · Bulkamid · COOK · COOK MEDICAL FLEXOR · COOK MEDICAL UROLOGY · Cook Medical Lasers · Cook Medical NGage · Cook Medical Stents · Cook Medical Urology · Cook Medical Urology SIS · Cook Medical Wire Guides · Deflux · ERLEADA · Erleada · FLOSEAL · GENERAL KIDNEY STONE DISEASE · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · General - Erectile Dysfunction · ILLUCCIX · INTERSTIM · IRRISEPT · Isiris aStent Removal Device · JELMYTO · KEYTRUDA · LYNPARZA · Lithotripters & Accessories · NANOKNIFE · Nubeqa · ORGOVYX · Olympus Cysto-Resection · POSLUMA · PYLARIFY · Polysorb · RESONANCE · REZUM · SPACEOAR · SPACEOAR VUE · SPEEDICATH · Solyx SIS System · TALZENNA · TITAN · Thiola · Titan · UROLIFT · UroLift · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in GA.

Looking for an urology physician in Augusta?
Compare urology physicians in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
31
Per 100K population
15.0
County median income
$53,197
Nearest hospital
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Klaassen is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of GA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Klaassen experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Klaassen performed 196 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Klaassen receive payments from pharmaceutical companies?
Yes. Dr. Klaassen received a total of $471,639 from 45 companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Klaassen's costs compare to other urology physicians in Augusta?
Dr. Klaassen's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Klaassen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →